jobs.jnj.com/en/jobs/
Skip to content

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.
Heart icon (animated) heart icon (static)
Check out this infographic breakdown of the company’s fourth-quarter and annual performance, with highlights from its Pharmaceutical, MedTech and Consumer Health businesses.
Women from historically underrepresented communities have a higher risk of pregnancy complications. So Johnson & Johnson Innovation challenged researchers to propose potential solutions that aim to address this troubling healthcare disparity. These awardees just might be the game changers.
Headshots of Dr. Kallenbach, Dr. Madduri and Dr. Cortoos
For National Cancer Prevention Month, we’re spotlighting three leading Johnson & Johnson female hematologists—innovators who are not only saving lives and advancing new treatments but also paving the way for the next generation of women in their field.
When the company was founded in 1886, sterile packaging wasn't yet available—so delivering its surgical supplies and household hygiene products to hospitals and consumers required ingenuity and design smarts. Here's the story of the changing face of packaging at Johnson & Johnson.
Mobilizing to help coworkers in need. Increasing diverse representation in clinical trials. Advocating on behalf of people living with life-altering medical conditions. Learn about the extraordinary ways these trailblazers made a difference in 2022.
In Kenya, around 1.5 million people—including children—contend with visual impairment or blindness. Sight for Kids, Johnson & Johnson Vision’s global eye care partnership, is devoted to changing these stats, one vision screening at a time.
Improvements in joint replacement techniques and technology have increased the effectiveness of this common procedure—yet some hip replacements still require a revision. Learn the latest about the surgery, plus how Johnson & Johnson is innovating to change this stat.
We spoke to a scientist behind a treatment for the disease that was recently FDA-approved for adolescents ages 12 to 18 to learn how it could give them new hope.
Back to top
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue